Key Insights

Highlights

Treatment Research

8 treatments under study, led by Azd4547

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

4Total
Phase 1/2 (1)
Phase 2 (3)

Trial Status

Unknown2
Recruiting1
Terminated1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07151040Phase 1/2Recruiting

Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors

NCT03957564Phase 2Unknown

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

NCT03829345Phase 2Unknown

A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

NCT01457846Phase 2TerminatedPrimary

Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

Showing all 4 trials

Research Network

Common Treatments

  • Azd45471
  • Olaparib1
  • Detect The Tumor Related Dna In Pathological Tissues After Operation1
  • Followup Of Dfs And Os In Patients With Gastric Cancer After Operation1
  • Th96191

Active Sponsors

  • AstraZeneca2
  • Affiliated Hospital of Qinghai University1
  • One-carbon Therapeutics AB1
  • Royal Marsden NHS Foundation Trust1

Top Investigators

Related Conditions

  • Gastric Cancer4
  • Oesophageal Cancer1
  • Solid Tumor1
  • Solid Tumors Including Nonsmall Cell Lung Cancer Nsclc Colorectal Cancer Crc Squamous Cell Carcinoma Of The Head And Neck Hnscc And Metastatic Breast Cancer1
  • Squamous Cell Carcinoma Of Head And Neck1

Activity Timeline